Breast cancer therapy that’s customized for each patient’s personal genetic makeup is one step closer to reality, thanks to a new use for crime-lab technology pioneered at Roswell Park Cancer Institute (RPCI). A team led by Petr Starostik, MD, chief of RPCI’s Clinical Molecular Diagnostics lab, is using CSI-type methods to multiply the reliability of [...]

The Northwest Regional Development Agency (NWDA) has approved an investment of almost £5 million for the development of a groundbreaking new project to support the Northwest’s biohealth sector and the public’s health.